论文信息 - Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study - 字舞流文

Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study

A. Teixeira-Carvalho | L. Castilho | O. Martins-Filho | J. D. de Oliveira | G. Fernandes | M. Nogueira | A. C. Campi-Azevedo | R. Grenfell | R. Alvim | P. Alves | Nathálie BF Almeida | P. S. Filgueiras | C. Corsini | Sarah VC Gomes | D. A. P. de Miranda | Adelina J. Lourenço | G. Campos | T. Lima | D. P. B. de Abreu | T. Silva | W. Jeremias | D. A. Otta | Ana Caroline Campi-Azevedo | D. Otta | N. B. Almeida | S. Gomes | Priscila Fernanda S Maria Luysa C Jessica V Viviane CF Edua Martins Pedrosa de Assis dos Santos de O | P. Filgueiras | A. Lourenço | D. D. de Miranda